XML 58 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Stock Options Awards and Restricted Stock Grants (Details) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average exercise price, granted $ 1.32 $ 4.16
Weighted average contractual terms, exercisable 6 years 5 months 8 days  
Share-Based Payment Arrangement, Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning balance 760,220  
Weighted average exercise price, beginning balance $ 4.55  
Options outstanding, granted 330,000  
Weighted average exercise price, granted $ 1.32  
Options outstanding, vested and issued  
Weighted average exercise price, vested and issued  
Options outstanding, Terminated (35,772)  
Weighted average exercise price, Terminated $ 10.61  
Options outstanding, ending balance 1,054,448  
Weighted average exercise price, ending balance $ 3.33  
Weighted average contractual terms 9 years 3 months 18 days  
Options outstanding, aggregate intrinsic value  
Options outstanding, exercisable 386,913  
Weighted average exercise price, exercisable $ 5.49  
Options outstanding, aggregate intrinsic value, exercisable  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Non-vested stock awards, beginning balance 69,650  
Weighted average grant date fair value, beginning balance $ 1.92  
Non-vested stock awards, granted 1,100  
Weighted average grant date fair value, granted $ 1.32  
Non-vested stock awards, vested and issued (200)  
Weighted average grant date fair value, vested and issued $ 4.60  
Non-vested stock awards, Terminated (200)  
Weighted average grant date fair value, Terminated $ 4.60  
Non-vested stock awards, ending balance 70,350  
Weighted average grant date fair value, ending balance $ 1.90  
Non-vested stock awards, aggregate intrinsic value